ArticleInfectious agents and cancer2025
Investigating the expression of HERV-K env, np9, gag, and rec in bladder cancers.
Article in Infectious agents and cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Human Endogenous Retroviruses and Diseases.MedComm · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
objectiveBladder cancer (BCa) has become a growing concern worldwide, highlighting the importance of early detection and new treatment methods. Recent studies have shown that viruses from the HERV family play a significant role in the development of various cancers and can act as early diagnostic biomarkers. Although hypomethylation of HERV-K has been proven in bladder cancer, no studies have yet explored the role of HERV-K oncogenes such as env, gag, np9, and rec. In this study, for the first time, we investigate the expression of these genes and their relationship with each other, aiming to shed light on their potential role in bladder cancer progression and diagnosis. METHODS AND MATERIALS: We collected a total of 42 samples, comprising 21 bladder transitional cell carcinoma (TCC) samples and 21 adjacent normal tissue samples. Following RNA extraction, the expression levels of HERV-K (HML-2) genes (env, gag, np9, and rec) were evaluated using quantitative real-time PCR (qRT-PCR). For statistical analysis, GraphPad software was employed, utilizing the Kruskal-Wallis test, Mann-Whitney U test, and correlation tests to assess the data.
resultsWe found that env and np9 were significantly upregulated in BCa tissues compared to normal tissues (p < 0.0001 and p = 0.022, respectively). While env showed strong associations with tumor grade (low-grade: p = 0.0006; high-grade: p = 0.0011) and stage (early stage: p = 0.0002; invasive stage: p = 0.0047), np9 exhibited consistent associations across all grades (low-grade: p = 0.017; high-grade: p = 0.042) but was exclusively linked to invasive stages (p = 0.001). Although gag expression did not differ significantly overall, it was elevated in the invasive stages of tumors (p = 0.0021). Interestingly, while rec expression showed an increase in cancerous tissues compared to normal tissues, this change was not statistically significant. However, it exhibited significant correlations with other HERV-K genes in cancerous tissue (r = 0.63, p < 0.0001 with env; r = 0.80, p < 0.0001 with gag; and r = 0.39, p = 0.015 with np9). Age-stratified analysis revealed tumor-specific env (p = 0.0272) and rec (p = 0.0017) variations, whereas normal tissues showed only marginal rec age-dependence (p = 0.0494).
conclusionThe results of our study highlight the potential role of HERV-K genes, particularly env and np9, in BCa progression and demonstrate their promising utility as diagnostic biomarkers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.